AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

GRI Bio, Inc. Director's Dealing 2021

Feb 10, 2021

35409_dirs_2021-02-09_e449f8bd-4e26-4939-a0ef-13c061ba47d8.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vallon Pharmaceuticals, Inc. (VLON)
CIK: 0001824293
Period of Report: 2021-02-09

Reporting Person: SALMON Pharma GmbH (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1476734	Direct